17hon MSN
Together with a team of international clinical researchers, Professor Dr. Oliver A. Cornely and Dr. Rosanne Sprute from ...
Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...
4h
News Medical on MSNProzac's surprising immune-boosting effects could lead to new treatments for sepsisAntidepressants like Prozac are commonly prescribed to treat mental health disorders, but new research suggests they could ...
5h
News Medical on MSNNew global guideline for Candida infections sets standards for diagnosis and treatmentTogether with a team of international clinical researchers, Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne have published the new global guideline for the ...
Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.
Together with a team of international clinical researchers, Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne have ...
Salk immunologists discover Prozac, an SSRI and one of the most prescribed drugs, protects against sepsis, wherein the body's ...
New research suggests that fluoxetine, commonly used as an antidepressant, may also help protect against infections and sepsis.
4d
GlobalData on MSNFDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results